03839oam 2200721I 450 99633912090331620230617042652.00-429-21587-81-280-24006-71-84692-550-91-280-26834-4978661024006797866102683440-203-02470-210.1201/b14809 (CKB)1000000000335688(EBL)362709(OCoLC)476194181(SSID)ssj0000258328(PQKBManifestationID)11194635(PQKBTitleCode)TC0000258328(PQKBWorkID)10256542(PQKB)10674566(OCoLC)958507957(Au-PeEL)EBL214981(OCoLC)62456369(Au-PeEL)EBL5299828(CaONFJC)MIL26834(MiAaPQ)54799(EXLCZ)99100000000033568820180706d2005 uy 0engur|n|---|||||txtccrTherapeutic strategies in COPD /edited by Mario Cazzola [and three others]First edition.Boca Raton, Florida :Clinical Publishing,2005.1 online resource (289 p.)Therapeutic StrategiesDescription based upon print version of record.1-904392-43-1 1-904392-42-3 Contents; Contributors; 1. COPD: molecular and cellular mechanisms; 2. Pathophysiology of airflow limitation in COPD; 3. Beta-adrenoceptor agonists: basic pharmacology; 4. Beta-adrenoceptor agonists: clinical use; 5. Anticholinergics: basic pharmacology; 6. The clinical use of anticholinergics; 7. Pharmacology of phosphodiesterase inhibitors; 8. Phosphodiesterase 4 inhibitors: a new class of agents for the treatment of chronic obstructive pulmonary disease; 9. Combination therapy with bronchodilators; 10. Corticosteroids: basic pharmacology; 11. Corticosteroids: clinical use12. The pharmacology of combination therapy with long-acting -adrenoceptor agonists and glucocorticoids in COPD13. The role of inhaled combination therapy with corticosteroids and long-acting b 2-agonists in the management of COPD; 14. Antioxidants and COPD; 15. Antiprotease therapy; 16. Mucoactive drugs; Abbreviations; Index"Three diseases are involved in most cases of chronic obstructive pulmonary disease (COPD): emphysema, chronic bronchitis, and asthma. All of these diseases are growing in prevalence in the Western world, most likely as a consequence of increased enrvironmental pollution and increased exposure to allergens. Reviewing current treatment options, Therapeutic Strategies in COPD helps doctors improve the quality of life of patients suffering from this disease. Each chapter is devoted to a specific group of drugs and features tables and graphs illustrating key points, trial results, and therapeutic protocols, presenting an authoritative and critical appraisal of each one. An integrated resource for the care of COPD patients, the book focuses on the basic mechanisms of action and pharmacology, therapeutic applications, and treatment strategies."--Provided by publisher.Therapeutic StrategiesLungsDiseases, ObstructiveTreatmentRespiratory organsDiseasesTreatmentLungsDiseases, ObstructiveTreatment.Respiratory organsDiseasesTreatment.616.24Cazzola M.Celli Bartolome R.Dahl RRennard S.FlBoTFGFlBoTFGBOOK996339120903316Therapeutic strategies in COPD2410525UNISA